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Seeing and doing: 
Feasibility study towards valuing visual impairment using simulation spectacles 
 
 
 
Abstract 
 
Elicitation of utilities from those who do not have the health condition of interest 
generally uses verbal description of health states. This paper reports on the results of a 
small-scale investigation on the feasibility of an alternative approach, where health 
states are simulated and thus directly experienced by respondents.  Three visual 
impairment health states were simulated using plastic spectacles, and were evaluated 
using the time trade-off. The first group of respondents (n = 19) found it difficult to 
assess visually impaired health states without referring to their own current health.  
With a further group of respondents (n = 14), we investigated the use of the 
respondents’ current health as the upper anchor of the time trade off.  Regression 
analysis shows that whilst there is a positive effect (p = 0.05) of the respondent’s own 
health state on the values from the first group, there is a non-significant negative 
effect (p = 0.36) on the values from the latter group with this revised method.  Thus, it 
is feasible to simulate visual impairment in valuation exercises, but care must be taken 
to ensure what health state is effectively being valued. 
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1. Introduction 
 
There are many issues associated with valuing health states, such as how those states 
should be valued and who should be asked to value them.(1;2)  Within this latter 
debate, a recurring theme is that subjects who do not have the condition in question do 
not know for real what it is like to be in the health state.  Advocates for values 
obtained from representative samples of the general public therefore stress the 
importance of informed public values.(3) This study addresses the issue of how to 
inform respondents of the health states to be valued.  When valuations are elicited 
from subjects who do not have the condition in question, the usual practice is to give 
them some form of verbal description of the state to be valued.  This can be done by 
using generic health state classification systems such as the EQ-5D(4), the Health 
Utility Index Mark 3 (HUI-3)(5), or the SF-6D(6), or by naming a condition, perhaps 
accompanied by a description of that condition.  Either way, the information given to 
respondents about the health state is highly selective. This means that a health state 
description may not provide the details that the respondent would have found relevant 
and important if they had been given complete information.   
 
Different approaches to presentation have also been taken.  For example, audiotapes 
for impaired speech(7) and video clips for other disabilities(8) have been used.  
These are alternative ways to “present” impaired states; respondents could hear or see 
a condition but not “experience” it.   
 
The objective of this small-scale study is to explore whether health states associated 
with progressive eye disease can be presented to non-patient respondents in the form 
of simulated states, so that the states are “experienced” by them.  In order to simulate 
visual impairment, large plastic spectacles, or goggles, representing different degrees 
of impaired vision are used.  This paper reports on the design and results of a 
feasibility study.  
 
 
2. Methods 
 
2.1 The basic structure of  the interviews 
 
The structure of the interviews is summarised in Figure 1 (version 1). All respondents 
were first asked to describe their own health in terms of the EQ5D, two questions on 
vision taken from the HUI-3, and three questions on visual function from the 
VFQ25(9).  These questions are referred to as “EQ5D+5” and are shown in Figure 2.   
 
Respondents were then asked to try on three pairs of spectacles, representing varying 
degrees of visually impaired health states, and to rank them in order of preference.  
Those respondents already wearing glasses could put the study spectacles on top. 
These three health states were then valued in a pre-determined order.  The spectacles 
representing the first state were handed to the respondent, and they were 
systematically invited to walk around the room, look at books and out of the window 
for a short time (one minute approximately). This was to help them to assess their 
ability to accomplish activities with visual impairment and the various implications of 
the condition on quality of life. All interviews took place at the same location, which 
 was unfamiliar to them. They were then asked to complete the EQ5D+5 questionnaire 
for that state, with spectacles on, with the help of the interviewer. They could then 
take the spectacles off for the valuation task, using the time trade-off (TTO) method.  
The procedure was repeated for the second and third states. 
 
There was a series of further exercises using health profiles, constructed from the 
three independent health states.  All material related to health profiles are reported in 
Appendix 3.  Finally, the respondent was asked a series of background questions, 
which were taken from the standard EQ-5D questionnaire and modified to ask about 
the respondent’s experience in visual impairment as opposed to severe illness in 
general. 
 
2.2 The health states and the t ime horizon variants 
 
Three health states (and two health profiles) representing visual impairment 
associated with an unspecified progressive eye disease were evaluated in this study.  
There is degrading vision, and a surgical intervention is available to prevent further 
visual loss, though damages caused by the disease cannot be reversed. The three states 
were designed after: mild visual impairment, severe visual impairment, and a post-
operative vision.  These were labelled A, B, and C respectively, and each respondent 
valued the states in this order, irrespective of their own ranking of the states.  
Spectacles A represent unambiguously better vision compared to B or C.  However, 
while spectacles B and C represent two different types of blurred vision, it was not 
obvious which represented better vision. 
 
When using the TTO method, a common duration across all respondents is sometimes 
specified.  For example, a 10-year fixed duration was used to generate the UK 
population value set for the EQ-5D(10).  However, a 10-year duration is unrealistic 
for respondents in the younger age groups.  On the other hand, a much longer time 
horizon will be unrealistic for older respondents.  Therefore, three respondent age 
groups were formed and different time horizons were used for each, to reflect roughly 
the differences in life expectancy across these groups, in line with the original 
formulation of the TTO method(11).   Respondents aged 60 and over were given a 10-
year time horizon variant, and those aged 40 to 59 were given a 20-year time horizon 
variant.  Furthermore, due to the study design related to the health profiles, there were 
two variants with a 40-year time horizon for younger respondents, aged 18 to 39.  
These two variants were identical with respect to the exercises on health states 
reported in this paper.  Therefore, they are pooled in this paper and in what follows 
we will refer to the three time horizon variants. 
 
2.3 Deriving values -  Introduction of  a second questionnaire version  
wi th a dif ferent TTO upper anchor 
 
The same TTO board and interviewer scripts(12) were used as in the study on 
Measuring and Valuing Health that estimated the UK EQ-5D population value set, 
with appropriate adjustments for different time horizons.  In version 1 of the 
questionnaire, TTO values for the three health states (and two profiles) were elicited 
in the standard way; that is, they were valued against a shorter period of time in full 
health.  Respondents were explicitly asked to ignore any possible comorbidity related 
to their present health state. The value of each state is given by T/T0, where T is the 
 number of healthy years equivalent to T0 years in the valued health state (or profile).  
For simplicity, a zero temporal discount is used.  However, some respondents seemed 
to be unable to ignore their present health conditions when asked to imagine 
themselves with the visual impairment alone.  So a revised protocol, version 2, was 
designed where the health state in question was now defined as the visual impairment 
in addition to present health (i.e. with existing health conditions).  To accommodate 
this change, the anchor for the TTO was also changed, from full health to present 
health. Thus, to each of the three time horizon variants described above, there are two 
versions with different upper anchors: version 1 with full health as the upper anchor, 
and version 2 with present health as the upper anchor. 
 
In version 2, to “chain” the value of each health state through the value of present 
health, a TTO valuation of present health against full health was introduced near the 
beginning of the interview (see Figure 1).  Assuming the disutility of multiple 
disabilities is additive (the “additivity assumption” hereafter), the values associated 
with visual impairment are then calculated as: 
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where Q represents quality of life, subscripts FHVI  and PHVI represent visual 
impairment anchored to full health and present health respectively, T* is the number 
of healthy years equivalent to T0 years in present health, and T** is the number of 
years of present health equivalent to T0 years in present health with visual impairment 
(see the Appendix 1 for a numerical example). 
 
Empirical evidence suggests that the additivity of multiple impairments assumption 
might lead to an overestimation of global disutility. For example applications of 
multi-attribute utility theory to establish a utility function for the HUI system have 
supported a preference interaction that can be approximated by a multiplicative multi-
attribute disutility relationship, with attributes being preference complements (i.e., 
dysfunction attributes are such that the loss in utility across multiple attributes is 
smaller than the sum of each loss occurring independently)(13). In the present study, 
therefore, a sensitivity analysis was performed using the assumption that the disutility 
of visual impairment with an existing health condition is halfway between the 
disutility of visual impairment alone and the sum of disutilities (we will refer to this 
as “partial additivity”; see Appendix 2 for details).  
 
2.4 The analyses 
 
As the respondents to each of the three time horizon variants were not equally 
distributed across the two upper anchor versions, pooling across the three variants 
could be a source of confounding bias in the comparison between the two versions. 
Therefore, in order to determine whether time horizon variants could be pooled, we 
tested for the association between elicited values and variants. As the sample size is 
small, the non-parametric Kruskall-Wallis test was used. Similarly the difference 
between upper anchor versions was tested statistically using the non-parametric 
Wilcoxon test, as there were two versions.  Given the small sample size, a 10% 
significance level is used throughout. 
 
 The effect of respondent’s own health on the valuations was explored by comparing 
the results across the two upper anchor versions.  This was done by regressing the 
TTO responses on categorical variables for the health states valued and the 
respondents’ self-reported health (expressed in terms of the EQ5D single index).  We 
used individual level responses and the random effects model to account for trends in 
individual responses.  The regression was run for the two versions separately and the 
coefficients were compared.  We used SAS version 8.2(14) for all analyses. 
 
2.5 The sample 
 
It was judged that around 40 interviews should be enough to establish whether or not 
the simulation approach is feasible and explore ways to address any difficulties 
encountered.  Therefore, allowing for possible dropouts, 50 participants were to be 
recruited.  Letters of invitation were sent out to 700 people randomly selected from 
the electoral register in two wards in Sheffield, UK.  The reply slip asked respondents 
to indicate their sex and age group, and to indicate which interview times they could 
make.  They were offered £15 to attend an interview at the University of Sheffield.   
 
 
3. Results 
 
In reply to the letters sent, 160 (23%) agreed to take part.  Amongst these, women and 
those aged 18-39 were over-represented relative to the general population. Of these, 
50 were invited for interview, making sure that there were equal numbers of men and 
women in each variant, and that there was an even spread across the time horizon 
variants1.  Of the 50 invitees, 38 (76%) turned up.  The first 5 interviews were treated 
as pilots for the purpose of interviewer training and to finalise the interview structure. 
This paper reports the results from the remaining 33 respondents. All interviews took 
place in the summer of 2001, and were conducted by one of the authors (SA).  
 
Table 1 shows the distribution of the 33 respondents across the three time horizon 
versions and the two upper anchor versions. Version 1 with full health as upper 
anchor had 19 respondents, and version 2 with present health as upper anchor had 14. 
 
Mean age was 46 years (SD=21), ranging from 20 to 86, and 45% were women. 
Interviews lasted between 27 and 117 minutes, and on average 42 minutes (STD=17). 
None of the interviews was aborted or produced missing values.  When asked for 
feedback, some patients commented about the TTO exercise, but there was no 
criticism relating to the simulation approach itself.     
 
Self reported health including vision is described in Table 2.  As can be seen, 45% 
reported problems on at least one EQ5D dimension.  The distribution of problems 
across the five dimensions are roughly comparable to those found in the above UK 
EQ-5D valuation study.(15)  Further, 9% indicated having experienced severe visual 
impairment themselves and 30% reported experience in their family.  Among the 14 
                                               
1 Because there were two 40-year time horizon variants, which are pooled for the purpose of 
this paper (see section 2.2 above), in effect, twice as many participants aged 18-39 were 
invited as those aged 40-59 and those aged 60+. 
 respondents who valued their present health in version 2, the mean TTO value was 
0.82 (STD=0.27).  
 
Table 3 reports mean TTO values by upper anchor version. Values for version 2 are 
standardised between full health and “dead”. While there is agreement across versions 
and variants that state A is better than states B and C, the relationship between the 
latter two states is not clear.  The values are not significantly different between time 
horizon variants (state A: p = 0.24; B: p = 0.36; C: p = 0.20; Kruskall-Wallis test).  
However, differences between upper anchor versions were statistically significant for 
two health states and marginal for the third (A: p = 0.09; B: p = 0.13; C: p = 0.03; 
Wilcoxon test).  Note that mean values for version 1 with full health as upper anchor 
were consistently lower than the mean values for version 2.  
 
Table 4 reports the results of the regression analysis. The last column indicates that 
there is no statistically significant difference in the intervals between the health states 
across the two upper anchor versions, and that a significant difference is attributable 
to the presence or absence of the effect of the respondent’s present health, and the 
version itself represented by the intercept.  Given the small sample size, some care is 
required to interpret this result: while the 90% confidence intervals for the intercepts 
do not overlap (-0.354 to 0.479 for version 1; and 0.502 to 1.434 for version 2), there 
is some overlap in confidence intervals for present health (0.110 to 1.030 for version 
1; and -0.766 to 0.285 for version 2). Similar results were observed when time 
horizon variants were adjusted for, as the variant effect was not statistically 
significant. Furthermore, this relationship between the versions is robust regarding the 
method of standardisation of the chained values in version 2: sensitivity analysis using 
the partial additivity assumption instead of the full additivity assumption resulted in 
mean values that were 0.09 lower for each state compared with the base case, but 
greater than with version 1. The effect of respondent’s present health in the regression 
analysis remained statistically non-significant (coefficient estimate: 0.016; p = 0.959; 
see Appendix 2 for details).   
 
 
4. Discussion 
 
The objective of this exploratory study was to examine the feasibility of presenting 
respondents with health states associated with visual impairment using simulation 
spectacles. Although the sample size was small, several interesting observations can 
be made.   
 
Experiencing visual impairment for a short time in order to value such a condition 
was generally well accepted by respondents. They reported in the EQ5D questionnaire 
that the condition was associated with some level of discomfort, as well as problems 
walking around. However the feedback was generally positive, suggesting 
acceptability, and several qualified this experience as “thought-provoking”. The fact 
that none of the respondents dropped out from the interview and that there were no 
missing values are positive indications with respect to the acceptability of this 
method.  
 
The most important and unexpected finding of this study is that some respondents 
found it difficult to imagine visual impairment alone when there was a pre-existing 
 disability.  (Note that between 40-50% of respondents reported some problem on at 
least one EQ-5D dimension, which itself is not unusual.)  This difficulty is not 
commonly reported in studies that use written descriptions.  It may be that, given 
verbal descriptions, those respondents who are not in full health are able to picture 
themselves firstly in the described health state (without their present condition) and 
secondly in full health (again, without their present condition).  Alternatively, they 
might not have been able to do this; and in this case, either the respondents simply did 
not recognise that they are not being able to do so, or they were aware of their 
difficulty but did not report it to the analyst. However, when the health state in 
question is simulated, as in this study, people found it markedly difficult to imagine 
themselves in the ways required.  This is likely to have happened because the 
simulated experience makes the health state more vivid and realistic, and so it 
becomes more difficult to imagine the health state in question without the pre-existing 
condition.  A further consideration is the case where the respondent’s condition 
happens to be some mild visual impairment.  In such cases it will be very difficult for 
the respondent to imagine herself with the simulated visual impairment alone, free of 
the pre-existing visual impairment. 
 
This finding was picked up after a dozen or so interviews, and led to the development 
of version 2.  The health state to be valued was changed from the visual impairment 
alone to the visual impairment alongside the existing conditions of the respondent, 
and the upper anchor of the TTO valuation was changed from full health to the 
respondent’s present health.  In order to standardise the obtained values, these values 
then had to be chained to full health via a TTO valuation of the respondent’s present 
health.  Whereas the chaining procedure is used here to deal with the upper anchor 
state, previous studies used chaining when “dead” was not acceptable to respondents 
as the bottom anchor, as they refused to compare minor health conditions against 
immediate death(16). However, the respondents of this study did not refuse to trade 
between survival and morbidity.  
 
The regression analysis shows that the responses from this version 2 are not affected 
by respondents’ own health level as those from version 1.  The regression coefficient 
for version 1 on the other hand indicates that a 0.1 increment in respondent health 
level will lead to a 0.06 increment in the TTO values. This contradicts earlier findings 
where the opposite relationship was observed where health states were verbally 
presented(17), but is consistent with the possibility that respondents in this study are 
not evaluating the simulated visual impairment alone, but are instead evaluating visual 
impairment alongside their existing health conditions.   
 
One of the two central assumptions concerning the chaining procedure used in this 
study is that it relies on constant proportional time trade-off of TTO responses (see 
Appendix 1).  Although the Kruskall-Wallis test across variants suggests that this 
assumption holds, since different time horizons used in this study correlate with 
respondent age, this result does not offer an appropriate test.  However, published 
studies suggest that, while the requirement is often violated at the individual level, it 
generally holds at the aggregate level (see for example Sackett and Torrance(18), 
Pliskin et al.(19), Buckingham et al.(20), Bleichrodt and Johannesson(21), and Unic et 
al.(22)). The second central assumption is the additivity assumption of multiple 
impairments.  The sensitivity analysis outlined in Appendix 2 demonstrated the 
robustness of the results of this study regarding this assumption. 
  
So, it seems that we are faced with a choice between the analytical simplicity of 
anchoring on full health and the cognitive ease of anchoring on present health, where 
there is no obvious correct choice.  However, we think that the second choice (using 
version 2) is better – it is certainly “kinder” to respondents. Moreover, the potential 
bias in version 1 goes only in one direction, because responses can be confounded by 
existing conditions, in which case the valuations will be biased downwards.  There is 
no such expected bias in version 2.  In this respect, it is interesting to note that TTO 
values from version 2 are consistently higher than those from version 1. 
 
Admittedly, this was an exploratory study, and as such it did not aim to have a 
sufficient sample size to detect pre-defined differences between the two versions (let 
alone to generate values to be used in future economic evaluation of interventions of 
visual impairment). Statistical methods were used as a tool to identify hypotheses to 
consider when eliciting utilities based on a simulation approach rather than to actually 
test such hypotheses. Although no attempt was made to evaluate the power of the 
reported tests, it was undoubtedly rather low. In particular, pooling of the three time-
horizon variants would have been avoided with a larger sample. 
 
Regarding the simulation approach itself, this is a way to provide more global 
information about the condition than by verbal descriptions, without risking cognitive 
overload.  Both for the practical objective of eliciting more realistic values for a given 
condition, and for the methodological objective of exploring the relationship between 
the evaluated health state and the respondents’ own health state, we believe that the 
use of simulations is a promising line of future research.  However, there are caveats 
to be noted.  Firstly, if the obtained values are to be used in the context of an 
economic evaluation of a specific intervention, then care must be taken to make the 
simulations as realistic as possible to the actual health states in question.  The whole 
point of the simulation approach is that rather than to present the main features of a 
condition, the condition as a whole is reproduced and experienced.  Secondly, most 
conditions would be ethically unacceptable to simulate even on consenting subjects.  
For instance, putting respondents through traumatic experiences is unlikely to be 
ethically acceptable.  Thus, only carefully selected conditions will be amenable to this 
simulation approach. 
 
In summary, there are three main conclusions from this study.  First, this study shows 
that valuing health states and profiles of visual impairment using simulation 
spectacles is feasible. This should encourage the development of studies to assess the 
validity of simulation-based elicitation of utilities compared to standard methods. 
Second, this study draws attention to the issue of what exactly it is that respondents 
are valuing when they are subjected to TTO exercises (and possibly other valuation 
methods) to evaluate themselves in hypothetical health states.  They may well be 
evaluating having the hypothetical health condition in addition to their current 
disabilities.  Third, this study has proposed a way to account for this potential 
problem, in a manner that does not impose extra burden on respondents other than one 
additional TTO question for their own current health state.  To the best of our 
knowledge, the second and third items are novel.  Given the small scale of this study, 
and the potential importance of the implications, they merit further detailed research. 
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Table 1. Distribution of respondents across variants and versions 
 
 Variant  
N (%) long horizon  
 for 18-39 
middle horizon 
for 40-59 
short horizon 
for 60+ 
Total 
Version 1  9 (27.27) 6 (18.18) 4 (12.12) 19 (57.58) 
Version 2 8 (24.24) 1 (3.03) 5 (15.15) 14 (42.42) 
Total 17 (51.52) 7 (21.21) 9 (27.27) 33 (100.00) 
 
Version 1: description and valuation of full health with visual impairment, anchored 
on full health. 
Version 2: description and valuation of present health with visual impairment, 
anchored on present health. 
 
 
  
Table 2: EQ5D+5 on respondents’ own health and the three health states A, B, 
and C 
 
Question Present 
health 
Health 
state ‘A’ 
Health 
state ‘B’ 
Health 
state ‘C’ 
EQ5D – Mobility  
- no problems walking about  
- some problems  
- bedridden 
 
79% 
21% 
0% 
 
55% 
45% 
0% 
 
0% 
91% 
9% 
 
3% 
91% 
6% 
EQ5D – Self care  
- no problems dressing or washing 
- some problems  
- unable 
 
97% 
0% 
3% 
 
70% 
27% 
3% 
 
12% 
79% 
9% 
 
6% 
79% 
15% 
EQ5D – Usual activities 
- no problems 
- some problems 
- unable 
 
88% 
9% 
3% 
 
21% 
67% 
12% 
 
0% 
21% 
79% 
 
0% 
42% 
58% 
EQ5D – Pain / discomfort 
- none 
- some 
- extreme 
 
76% 
21% 
3% 
 
55% 
45% 
0% 
 
27% 
52% 
21% 
 
27% 
48% 
24% 
EQ5D – Anxiety / depression 
- not anxious or depressed 
- moderately 
- extremely 
 
79% 
21% 
3% 
 
48% 
42% 
9% 
 
15% 
42% 
42% 
 
5% 
39% 
45% 
EQ5D – Full health 55% 12% 0% 0% 
HUI3 – Ability to read 
- able without glasses 
- able with glasses  
- unable to see well enough with glasses 
- unable at all 
 
52% 
48% 
0% 
0% 
 
18% 
45% 
36% 
0% 
 
0% 
3% 
97% 
0% 
 
0% 
0% 
100% 
0% 
HUI3 – Ability to recognise a friend 
- able without glasses 
- able with glasses  
- unable to see well enough with glasses 
- unable at all 
 
64% 
36% 
0% 
0% 
 
21% 
61% 
18% 
0% 
 
0% 
6% 
94% 
0% 
 
0% 
3% 
97% 
0% 
 
 
  
Table 3. TTO valuations of health states  
 
Version 
version 1 version 2 
Variant Variant  
18-39  40-59 60+ 
All 
variants 
pooled 18-39  40-59 60+ 
All 
variants 
pooled 
Current 
health - - - - 0.88 0.33 0.82 0.82 
State A 0.64 0.40 0.62 0.56 0.80 0.75 0.71 0.76 
State B 0.36 0.25 0.26 0.30 0.53 0.68 0.42 0.50 
State C 0.39 0.16 0.26 0.29 0.55 0.68 0.52 0.55 
 
  
Table 4. Results of the regression analysis:  effect of the respondent’s present 
health on TTO valuations  
 
Version 1 Version 2 
 
B1 p B2 p 
p-value 
B1=B2 ‡ 
Present health 0.559 0.0516 -0.291 0.3636 0.0515 
State B -0.254 0.0002 -0.266 0.0007 0.8974 
State C -0.266 0.0000 -0.216 0.0015 0.5503 
State A † 0 - 0 - - 
Constant 0.072 0.7748 1.010 0.0011 0.0180 
 
†  State A is the default dummy. 
‡  The p-values of the Wald test: B1 = B2. 
 
 
  
Figure 1: Structure of the two interview versions 
 
         version 1        version 2 
            (n = 19)         (n = 14) 
 
(1)  describing present health in EQ5D+5†     ü   ü  
(2)  TTO of present health    ´  ü  
(3)  ranking of visual states A, B, C   ü   ü   
(4)  visual state A 
 (a) describing state A in EQ5D+5  ü   ü 
 (b) TTO of state A    ü  ü   
(5)  visual state B 
 (a) describing state B in EQ5D+5  ü   ü 
 (b) TTO of state B    ü    ü  
(6)  visual state C 
 (a) describing state C in EQ5D+5  ü   ü 
 (b) TTO of state C    ü    ü   
(7)  ranking of states A, B, C, and profiles X, Y ü   ü  
(8)  TTO of profile X     ü    ü  
(9)  TTO of profile Y     ü    ü  
(10) WTP for difference Y-X    ü   ü 
 
 
† EQ5D+5 consists of EQ5D, 2 questions on vision from HUI-3, and 3 selected questions from 
VFQ25. 
 
In version 1, TTO of the state/profile alone, with immediate death and full health as anchors. 
In version 2, TTO of state/profile plus present existing disabilities, with immediate death and 
present health as anchors. 
 
This paper reports on the results from (1) to (6). 
 
 
 
  
Figure 2: The “EQ5D+5” 
 
 
EQ5D 
(1) Mobility 
à no problems walking about / some problems / bedridden 
 
(2) Self Care 
à no problems dressing or washing / some problems / unable 
 
(3) Usual Activities 
à no problems / some problems / unable 
 
(4) Pain/Discomfort 
à none / some / extreme 
 
(5) Anxiety/Depression 
à not anxious or depressed / moderately / extremely 
 
 
HUI-3 
(6) Which one of the following would best describe your ability, during the past 
week, to see well enough to read ordinary newsprint? 
à able without glasses / able with glasses / unable to see well enough with 
glasses / unable at all 
 
(7) Which of the following would best describe your ability, during the past week, 
to see well enough to recognize a friend on the other side of the street? 
à able without glasses / able with glasses / unable to see well enough with 
glasses / unable at all 
 
 
VFQ-25 
(8) At the present time, would you say your eyesight in both eyes (with glasses 
or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor, 
or are you completely blind? 
 
(9) Do you accomplish less than you would like to because of your eyesight? 
à 5 levels from “All of the Time” to “None of the Time”. 
 
(10) I need a lot of help from others because of my eyesight. 
à 5 levels from “Definitely True” to “Definitely False” 
 
 
Note that these are summaries to illustrate the items included in EQ5D+5 and does 
not reproduce the exact wording. 
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Figure 3. An example of utility calculation with the “chained” procedure 
represented on the utility scale 
 
 
 
 
 
 
 
      
0 0.2 0.4 0.6 0.8 1 
PHVI: Present Health with Visual Impairment 
FHVI: Full Health with Visual Impairment 
FH: Full Health 
PH: Present Health
Dead 
FH 
PH 
(8/10).FH 
PHVI 
(5/10).PH 
FHVI 
PHVI+(FH-PH) 
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Appendix 1: An example of anchoring visual impairment on present health 
 
 
Suppose a respondent is asked to value visual impairment (VI) with his present health 
condition (PHVI), using TTO with a time horizon of 10 years.  The anchoring state is 
present health (PH).  Suppose further that this respondent is indifferent between 5 
years in his present health with no visual impairment and 10 years in his present 
health with visual impairment. 
 
From this observation, we want to deduct the utility associated with full health with 
visual impairment (FHVI) on a scale anchored on dead (utility: 0) and full health (FH; 
utility: 1).  In order to do so, the respondent is asked to value his present health 
against full health.  Let us assume that he is indifferent between 8 years in full health 
and 10 years in present health (see Figure 3). 
 
Since: 
5 years in present health = 10 years in present health with visual impairment, 
then, using the constant proportional time trade-off assumption:  
10 years in present health = 20 years in present health with visual impairment. 
Furthermore,  
8 years in full health = 10 years in present health. 
Then, by transitivity: 
8 years in full health = 20 years in present health with visual impairment. 
  
The last statement implies that the utility associated with present health with visual 
impairment is 0.4.  To calculate the utility associated with full health alone (without 
visual impairment), the value of the difference between present health and full health 
needs to be added.  Given that the utility of full health is 1 and the utility of present 
health is 0.8, the difference is 0.2.  Thus, the utility of full health with visual 
impairment is 0.6. 
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Appendix 2: Sensitivity analysis on the additivity assumption of comorbidities 
 
 
Should one consider that dysfunction attributes are “dispreference” substitutes (i.e., 
the disutility of multiple impairments is less than the sum of disutilities), a 
multiplicative multi-attribute utility function would ideally be fitted. However, the 
protocol was not designed as an application of multi-attribute utility theory(23). 
Therefore, an alternative approximation was used for the purpose of a sensitivity 
analysis.  
 
In the example above (appendix 1), we would consider that the disutility of visual 
impairment with and existing health condition (0.6) is less than the sum of the 
disutility of visual impairment alone and the disutility of the existing health condition 
(0.2). This implies that the disutility of visual impairment alone exceeds 0.4, and so it 
lies in the range [0.4, 0.6]; we assumed that it was the midpoint of this range. Thus the 
equation (E1) was amended as following: 
( ) ( ) ( )( ) ÷÷
ø
ö
çç
è
æ
-+=-+=
0
2
0
*1
2
1**.*1
T
T
T
TTQUQUQU PHPHVIFHVI , (E2) 
using the same notations as in the text above. We refer to this assumption as “partial 
additivity”, as opposed to full additivity. Note that this modification does not affect 
intervals between elicited values. 
21 
 
Appendix 3: Additive separability of health states in profiles 
 
 
A3.1. Introduction 
 
As is stated in the main text, the study also included a series of exercises on two 
health profiles, composed of the three health states A, B, and C, in this order.  This 
Appendix reports on the findings related to these.  The objective is to test whether or 
not the preference for a health profile is equal to the weighted sum of the preferences 
of the composite health states (weighted by the duration of each state).  This is related 
to the additive separability condition, that the value of a health state should be 
independent of what precedes or follows it, which is necessary for the aggregation of 
the value of health states across time to produce the value of a health profile.  The 
alternative hypothesis is that the value of a declining health profile will be less than 
the weighted average of the composite health states.(24)  
 
A3.2. Methods 
 
The first profile, X, represented the natural progression of the disease from mild to 
severe visual impairment, followed by the post-operative state (A - B - C).  The 
second profile, Y, represented the pathway with a medical intervention that slowed 
down the progression of the disease, so that it took longer to move from state A to 
state B, and thus to state C: i.e. the timing of the operation was delayed.  In either 
profile, no account was made of the transition from state B to C: i.e. the pain, trauma 
and discomfort associated with the laser operation itself.    
 
Taking the 40-59 age group as the reference case, the baseline for profile X was 10-4-
6: i.e. 10 years in the mild state, 4 years in the severe state, and 6 years in the post-
operative state.  Profile X for the 60+ age group was proportional to this: i.e. 5-2-3. 
Under the assumptions of additive separability and constant proportional time trade-
off, the same values would be expected for proportional health profiles 10-4-6 and 5-
2-3, after adjustment for time-preference. The 18-39 age group was broken up into 
two subgroups.  The first subgroup was given a profile that was proportional to the 
reference case, i.e. 20-8-12.  However, should respondents have a positive rate of 
time-preference, elicited values would be little sensitive to the time spent in the last 
states. Therefore, the second subgroup was given a profile comprising of 10-4-26, 
which means the first 20 years of their time horizon is split in the same way (10-4-6) 
as in the reference case. Respondents aged between 18 and 39 were allocated 
randomly to one of these two subgroups. 
 
The baseline for profile Y was generated by extending the duration of the mild state 
by 4 years and leaving the duration of the severe state unchanged, thus delaying the 
post surgery state by 4 years.  Therefore, Profile Y for the 40-59 age group was 14-4-
2.  Retaining proportionality, Profile Y for the 60+ group becomes 7 years in the 
moderate state, followed by 3 years in the severe state, with no post-operative state (7-
3).  Profile Y for the two 18-39 subgroups was constructed following the rules above, 
resulting in health profiles of 28-8-4 and 14-4-22. Thus, there are now four time 
horizon variants: “10-year time horizon variant”, “20-year time horizon variant”, “40-
year time horizon F”, and “40-year time horizon P” (where “F” and “P” for the 40-
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year time horizon variants stand for fixed and proportional health profiles).  The 
durations and health profiles are summarised in Figure A3. 
 
After the TTO of the individual health states, the two health profiles were presented to 
the respondents and they were asked to rank them alongside the three states.  They 
then valued each of the two health profiles to provide direct TTO valuations.  The 
profiles were presented in the form of a diagram showing the different durations of 
the three states (Figure A3).   
 
Since health profiles X and Y are combinations of states A, B, and C, and since all the 
states and profiles evaluated by a given respondent last for the same total duration, 
there is a logical ordering to the health states and profiles, enabling to test for internal 
inconsistencies.  A respondent was defined as “inconsistent” if his (direct) TTO 
valuations did not reflect either of the following orderings: A f Y f X f B f C, or A 
f Y f X f C f B.  The difference between the severe and post-operative states is not 
obvious and so C f B was not treated as an inconsistency.   
 
Further, indirect TTO values for profiles X and Y were calculated for each individual, 
using the TTO values of composite states A, B, and C.  A zero time preference rate is 
used in the initial stage.  Should the direct and indirect values differ, a time preference 
rate that will make them coincide at the aggregate level will be calculated. 
 
A3.3. Results 
 
At the individual level, a small number of respondents (three from version 1 and one 
from version 2) violated the relationship that profile X is better than the worst state 
(the smaller of B and C). However, the consistency rates were very good overall. 
 
Table A3.1 reports the aggregated direct and indirect TTO values for profiles X and 
Y, including those with inconsistent results.  the indirect values for profile Y are 
higher than for profile X. It can be seen that the difference across versions is greater 
than the difference between profiles within a version. Comparison with Table 3 
indicates that, at zero temporal discount, the direct values of the declining profile are 
lower than the corresponding indirect values, thus violating additive separability. The 
temporal discount rates at which the direct and indirect values of these profiles 
coincide are negative (-10% for X and -12% for Y). 
 
Table A3.2 illustrates the results of the regression analysis, by including the direct 
TTO values of the two profiles.  As can be seen, the observations made in the main 
text continue to apply. 
 
A3.4 Discussion 
 
Few respondents had ordinal inconsistencies in the TTO responses and the differences 
in TTO values between the different health states and profiles were robust across two 
versions of the protocol. Arguably, defining certain rank ordering of TTO values as 
“inconsistent” when the states have no logical ordering may be problematic.  
However, all the cases of inconsistency in the rank ordering of TTO values occurred 
where this ordering did not follow the direct rank ordering of the health states and 
profiles by the same respondent. Thus, these so-called “inconsistencies” might reflect 
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measurement error associated with the TTO method rather than unexpected 
preferences.  
 
The results regarding the direct and indirect values for the two health profiles suggest 
the violation of additive separability at the aggregate level, under the zero discount 
rate assumption.  The present results are consistent with the theoretical concern over 
this assumption that predicts direct values of declining profiles will be lower than 
their indirect values.  If we relax the zero discount assumption, then the present results 
are consistent with additive separability if discounting is negative.  Negative time 
preference has been observed in other studies.(25)  However, a negative time 
preference rate would imply that preference weights for life-years would increase 
exponentially with time. Hence values elicited with a 40-year time horizon would 
likely exceed values elicited with 20- or 10-year time horizons.  For example, if an 
individual values a state at 0.5 and has a time preference rate of -10%, the expected 
elicited values non-adjusted for temporal discounting would be approximately 0.60 
with a 10-year time horizon, 0.71 with 20-year and 0.82 with 40-year time horizon. 
This type of trend is not apparent in the comparison between variants.  However, it is 
unclear whether the data are consistent with negative discounting as differences 
between variants are not significant, and valuations may also depend on age (1). 
Perhaps a possible explanation is that respondents considered that the fear of future 
degradation of vision would affect their quality of life and would make more difficult 
the adaptation to visual impairment. 
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Table A3.1. Direct and indirect TTO values for profiles X and Y 
 
version 1 version 2 
 
direct indirect direct indirect 
Profile Y (with intervention) 0.41 0.45 0.61 0.68 
Profile X (without intervention) 0.34 0.41 0.57 0.64 
n 19 14 
 
 
 
 
 
 
 
Table A3.2. The effect of the respondent’s present health on TTO valuations  
 
Version 1 Version 2 
 
B1 p B2 p 
p-value 
B1=B2 ‡ 
Present health 0.570 0.044 -0.241 0.443 0.058 
State B -0.254 0.000 -0.266 0.001 0.897 
State C -0.266 0.000 -0.216 0.001 0.550 
Profile X 
(direct) -0.214 0.000 -0.194 0.003 0.792 
Profile Y 
(direct) -0.149 0.001 -0.153 0.003 0.948 
State A † 0 - 0 - - 
Constant 0.063 0.800 0.968 0.001 0.020 
 
†  State A is the default dummy. 
‡  The p-values of the Wald test: B1 = B2. 
 
 
 
 
 
 Figure A3:  The two profiles and the four variants  
 
Fig A3.a Profiles for the 18-39 age group, variant ‘18P’ 
Profile X, Variant 18P
20 8 12
0 10 20 30 40
years
Profile Y, Variant 18P
28 8 4
0 10 20 30 40
years
 
 
Fig A3.b Profiles for the 18-39 age group, variant ‘18F’ 
Profile X, Variant 18F
10 4 26
0 10 20 30 40
years
Profile Y, Variant 18F
14 4 22
0 10 20 30 40
years
 
 
Fig A3.c Profiles for the 40-59 age group 
Profile X, Variant 40
10 4 6
0 5 10 15 20
years
Profile Y, Variant 40
14 4 2
0 5 10 15 20
years
 
 
Fig A3.d Profiles for the 60 and above age group 
Profile X, Variant 60
5 2 3
0 2.5 5 7.5 10
years
Profile Y, Variant 60
7 3
0 2.5 5 7.5 10
years
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